EGFR stage IV population in FJD

Patients diagnosed with metastatic EGFR-mutated NSCLC who were treated in four hospitals in Madrid, Spain. The characteristics of these patients were analyzed. We selected those diagnosed between March 2021 and February 2023, coinciding with the implementation of next-generation sequencing (NGS) as part of routine clinical practice for lung cancer patients in our centers.